Alexander Finlayson
- Public Health, Environmental and Occupational Health top 10%
- Economics and Econometrics top 5%
- General Health Professions top 10%
- Molecular Biology
- Oncology
- Co-authors
- Brian GodmanRaghib AliIsobel BarnesG. TowersZ. AbramowskiMarion BennieStephen CampbellKevin W. Freeman
- Topics
- Pharmaceutical Economics and Policy (10 papers)Health Systems, Economic Evaluations, Quality of Life (8 papers)Pharmaceutical industry and healthcare (5 papers)
- Journals
- PLoS ONEGutBritish Journal of Cancer
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Alexander Finlayson
52 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 146
- Public Health, Environmental and Occupational Health 191
- Economics and Econometrics 177
- General Health Professions 160
- Molecular Biology 103
- Oncology 93
Countries citing papers authored by Alexander Finlayson
This map shows the geographic impact of Alexander Finlayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Finlayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Finlayson more than expected).
Fields of papers citing papers by Alexander Finlayson
This network shows the impact of papers produced by Alexander Finlayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Finlayson. The network helps show where Alexander Finlayson may publish in the future.
Co-authorship network of co-authors of Alexander Finlayson
This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Finlayson. A scholar is included among the top collaborators of Alexander Finlayson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Finlayson. Alexander Finlayson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 21 | |
| 3 | 57 | |
| 4 | 37 | |
| 5 | 28 | |
| 6 | Initiatives to improve prescribing efficiency in China and their influence : cardio-cerebral vascular medicines as a case history to provide future direction | 1 |
| 7 | Correction: Childhood cancer incidence in British Indians & Whites in Leicester, 1996-2008 (PLoS ONE (2013) 8, 4 (e61881) DOI:10.1371/journal.pone. 0061881) | 1 |
| 8 | 33 | |
| 9 | 22 | |
| 10 | 18 | |
| 11 | 9 | |
| 12 | 18 | |
| 13 | 3 | |
| 14 | 3 | |
| 15 | 68 | |
| 16 | 2 | |
| 17 | 2 | |
| 18 | 4 | |
| 19 | 60 | |
| 20 | Is psychiatry being harmed by involuntary hospitalization and treatment | 1 |
About Alexander Finlayson
Alexander Finlayson is a scholar working on Pharmacology, Geriatrics and Gerontology and Finance, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Pharmaceutical industry and healthcare (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (26 citations), Geriatrics and Gerontology (47 citations) and Family Practice (17 citations). Alexander Finlayson has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include Brian Godman, Raghib Ali, Isobel Barnes, G. Towers, Z. Abramowski, Marion Bennie, Stephen Campbell, Kevin W. Freeman, J. McEwen and A. A. M. Gibson. Their work appears in journals such as PLoS ONE, Gut and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.